Diseases, Conditions, Syndromes

Updated COVID-19 boosters and XBB.1.5: What you need to know

As the world marches toward the completion of its fourth year with COVID-19, data from the U.S. Centers for Disease Control and Prevention (CDC) show that the majority of those infected, hospitalized or dying from the SARS-CoV-2 ...

Medical research

Study finds serotonin reduction causes long COVID symptoms

Patients with long COVID—the long-term symptoms like brain fog, fatigue, or memory loss in the months or years following COVID-19—can exhibit a reduction in circulating levels of the neurotransmitter serotonin, according ...

Diseases, Conditions, Syndromes

An AI tool that can help forecast viral outbreaks

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.

Vaccination

FDA approves updated Novavax COVID vaccine

Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines.

Diseases, Conditions, Syndromes

Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Diseases, Conditions, Syndromes

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including SARS-CoV-2 has been developed by scientists at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.

Medications

Antiviral drug molnupiravir linked to SARS-CoV-2 mutations

Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 ...

page 4 from 40